With a total artificial heart powered by a backpack-sized power supply, Stan Larkin, 24, can wait at home for a heart transplant. He is part of a rare group of U.S. patients who have been discharged from a hospital without a human heart.
A global hunt for genes that influence heart disease risk has uncovered 157 changes in human DNA that alter the levels of cholesterol and other blood fats – a discovery that could lead to new medications.
It was called the biggest comeback in Big House history when Leo Staudacher suffered cardiac arrest at the University of Michigan-Notre Dame game. Two years later he says it was the best thing that could have happened to get his health on track.
Stroke rates have declined in the past decade, but there's still work to be done by the University of Michigan Frankel Cardiovascular Center and its partners in Corpus Christi, Texas, to prevent stroke among young Mexican Americans.
Michigan’s top heart and heart surgery program has a new name – the University of Michigan Samuel and Jean Frankel Cardiovascular Center. The change recognizes $50 million in giving from the Samuel and Jean Frankel Foundation.
During Heart Disease Awareness Month, experts at the U-M Cardiovascular Center are available to discuss new strategies for improving patient care and the quality of patients' lives. While cutting-edge techniques are transforming treatment of heart disease, there are ways to prevent getting heart disease in the first place.
Want to know how well UMHS does at providing high-quality care and protecting patients' safety while they receive care? Check out the newly updated data on a website that provides these data, patient ratings of UMHS care, and much more, to the public.
The University of Michigan Cardiovascular Center, a leader in heart valve replacement, has performed its first minimally invasive aortic valve replacement. Designed to replace a diseased aortic heart valve percutaneously, the procedure potentially provides a safe and less invasive alternative to open heart surgery.
The University of Michigan Cardiovascular Center is part of the national Medtronic CoreValve trial to replace diseased valves with a minimally invasive procedure. It's a potentially transformative option for aortic stenosis patients who cannot tolerate open heart surgery.